OM

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Outset Medical Inc

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.
CEO
Employees
313
Headquarters

News

Can you now get a good deal on Outset Medical Inc.’s shares?
Nov 25, 2022 15:24pm

A share of Outset Medical Inc. (NASDAQ:OM) closed at $19.94 per share on Wednesday, up from $17.94 day before. While Outset Medical Inc. has overperformed by 11.15%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, OM fell by -58.92%, with highs and lows ranging from $51.69 […]


Source:US Post News
Outset Medical Ranked Number 33 Fastest-Growing Company in North America on the 2022 Deloitte Technology Fast 500
Nov 16, 2022 14:09pm

Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, announced it ranked 33 on the Deloitte Technology Fast 500, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech and energy tech companies in North America, now in its 28th year. Outset revenue grew 5,000


Source:Wallstreet:Online
Investing in Outset Medical Inc. (OM) might be an excellent idea, but the stock is currently overvalued/undervalued
Nov 15, 2022 16:40pm

The share price of Outset Medical Inc. (NASDAQ:OM) rose to $18.15 per share on Monday from $17.88. While Outset Medical Inc. has overperformed by 1.51%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, OM fell by -64.31%, with highs and lows ranging from $55.41 to $11.41, […]


Source:US Post News
UPDATE: RBC Capital Starts Outset Medical Inc. at Outperform
Nov 11, 2022 10:45am

https://www.investing.com/news/pro/rbc-capital-starts-outset-medical-inc-at-outperform-432SI-2941199


Source:Investing.com
AMRS and MACK among mid-day gainers
Nov 09, 2022 18:13pm

Gainers: Merrimack Pharmaceuticals (MACK) +197%.NeuroBo Pharmaceuticals (NRBO) +44%.Outset Medical (OM) +36%.OptimizeRx (OPRX) +30%.Kala Pharmaceuticals (KALA) +27%.Health Catalyst…


Source:Seeking Alpha
Crude Oil Down Over 2%; Outset Medical Shares Spike Higher
Nov 09, 2022 17:19pm

U.S. stocks traded lower midway through trading as investors focused on the outcome of the midterm elections. The Dow traded down 0.64% to 32,950.16 while the NASDAQ fell 0.76% to 10,535.77. The S&P 500 also fell, dropping, 0.59% to 3,805.51. Also check this: Ethereum Dips Below $1,200; FTX Token, Solana Among Biggest Losers Leading and Lagging Sectors Real estate shares gained 0.7% on Wednesday. Leading the sector was strength from Forestar Group Inc. (NYSE: FOR ) and American Realty Investors, Inc. (NYSE: ARL ). In trading on Wednesday, energy shares dipped by 2.5%. Top Headline US crude oil inventories increased by 3.925 million barrels in the week ended November 4th, versus market estimates of a 1.360-million-barrel rise, the Energy Information Administration said. Equities Trading UP Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) shares shot up 198% to $11.93 after partner Ipsen reported Onivyde met its primary and key secondary endpoint. Merrimack is eligible for up to $450 million in milestone payments for the pancreatic cancer treatment.


Source:Benzinga
Meta Platforms, Hilton Grand Vacations, D.R. Horton, And Some Other Big Stocks Moving Higher On Wednesday
Nov 09, 2022 15:54pm

U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Wednesday. Here are some big stocks recording gains in today’s session. Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) shares climbed 219% to $12.80 after partner Ipsen reported Onivyde met its primary and key secondary endpoint. Merrimack is eligible for up to $450 million in milestone payments for the pancreatic cancer treatment. Outset Medical, Inc. (NASDAQ: OM ) surged 36.1% to $15.61 after the company reported better-than-expected Q3 results. OptimizeRx Corporation (NASDAQ: OPRX ) climbed 28% to $18.58 following better-than-expected Q3 results. Health Catalyst, Inc. (NASDAQ: HCAT ) rose 23% to $7.95 after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY22 sales guidance above analyst estimates. Vivint Smart Home, Inc. (NYSE: VVNT ) gained 21.4% to $8.50 after the company posted upbeat quarterly sales and raised FY22 revenue guidance. LiveRamp Holdings, Inc. (NYSE: RAMP ) rose 21% to $18.91 after the company reported better-than-expected Q2 results and issued strong guidance.


Source:Benzinga
US Stocks Open Lower; Dow Drops 250 Points
Nov 09, 2022 15:10pm

U.S. stocks traded lower this morning as investors focused on the outcome of the midterm elections, with the Dow Jones dropping around 250 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.76% to 32,907.76 while the NASDAQ fell 1.04% to 10,505.93. The S&P 500 also fell, dropping, 0.79% to 3,797.68. Also check this: Ethereum Dips Below $1,200; FTX Token, Solana Among Biggest Losers Leading and Lagging Sectors Health care shares gained 0.2% on Wednesday. Leading the sector was strength from Health Catalyst, Inc. (NASDAQ: HCAT ) and Outset Medical, Inc. (NASDAQ: OM ). In trading on Wednesday, energy shares dipped by 2%. Top Headline D.R. Horton, Inc. (NYSE: DHI ) reported weaker-than-expected Q4 results. D.R. Horton posted quarterly earnings of $4.67 per share, missing analysts’ estimates of $5.09 per share. The company’s quarterly sales came in at $9.64 billion, versus expectations of $9.97 billion. D R Horton said it sees consolidated revenues For Q1 of $6 billion to $6.8 billion.


Source:Benzinga
A stock that deserves closer examination: Outset Medical Inc. (OM)
Nov 09, 2022 12:00pm

In Tuesday’s session, Outset Medical Inc. (NASDAQ:OM) marked $11.47 per share, down from $12.40 in the previous session. While Outset Medical Inc. has underperformed by -7.50%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, OM fell by -79.10%, with highs and lows ranging from $59.01 to […]


Source:US Post News
Outset Medical, Inc. (OM) Q3 2022 Earnings Call Transcript
Nov 09, 2022 04:10am

Outset Medical, Inc. (NASDAQ:NASDAQ:OM) Q3 2022 Earnings Conference Call November 08, 2022 5:00 PM ET Company Participants Jim Mazzola – Vice President-Investor Relations Leslie Trigg –…


Source:Seeking Alpha
Outset Medical, Inc. 2022 Q3 - Results - Earnings Call Presentation (NASDAQ:OM)
Nov 08, 2022 23:10pm

The following slide deck was published by Outset Medical, Inc.


Source:Seeking Alpha
Outset Medical Non-GAAP EPS of -$0.70 in-line, revenue of $27.8M beats by $2.57M (NASDAQ:OM)
Nov 08, 2022 22:33pm

Outset Medical press release (OM): Q3 Non-GAAP EPS of -$0.70 in-line.Revenue of $27.8M (+5.7% Y/Y) beats by $2.57M.Full Year 2022 Financial Guidance- Outset now projects revenue for…


Source:Seeking Alpha
Outset Medical Reports Third Quarter 2022 Financial Results
Nov 08, 2022 21:05pm

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the third quarter ended September 30, 2022. Recorded net revenue of $27.8 million in the third quarter of 2022, a 5.5% increase compared to $26.3 million in the third quarter of 2021 and a 10.8% increase compared to $25.1 million in the second qu


Source:Business Wire
Outset Medical gets up to $300M in debt financing (NASDAQ:OM)
Nov 04, 2022 12:37pm

Outset Medical (OM) has entered into two senior secured credit facilities with investment affiliates managed by SLR Capital Partners which collectively provide for borrowings of up…


Source:Seeking Alpha
Outset Medical to Report Third Quarter 2022 Financial Results Tuesday, November 8, 2022
Oct 26, 2022 20:05pm

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the third quarter of 2022 after the close of trading on Tuesday, November 8, 2022. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Leslie Trigg, Chief Executive Officer, and Nabeel Ahmed, Chief Financial Officer, will host a


Source:Business Wire
Outset Medical Inc. (NASDAQ: OM) Stock Dropped -18.05% Over A Month – Is There Any Hope Of A Gain?
Oct 08, 2022 16:00pm

During the last session, Outset Medical Inc. (NASDAQ:OM)’s traded shares were 0.48 million. At the end of the trading day, the stock’s price was $14.66, reflecting an intraday loss of -9.34% or -$1.51. The 52-week high for the OM share is $60.33, that puts it down -311.53 from that peak though still a striking 9.62% … Outset Medical Inc. (NASDAQ: OM) Stock Dropped -18.05% Over A Month – Is There Any Hope Of A Gain? Read More »


Source:Marketing Sentinel